High-efficient Nonviral Transfection of the Rat Thyroid Cell Line FRTL-5

Abstract

FRTL-5 cells are used in many laboratories as an in vitro system of thyroid follicular cells since they share many properties of human thyrocytes. However, the use of FRTL-5 cells for experimental modifications is limited by low transfection efficiencies of lipid-based transfections and the need for cumbersome viral transduction protocols. A new technology – nucleofection – has become available for cell lines that are difficult to transfect. Here, we report the application and optimization of this method in FRTL-5 cells. Using the green fluorescent protein (GFP) as a reporter gene, FRTL-5 cells were easily transfectable with efficiencies over 60%. In addition, the simultaneous transfer of siRNA against GFP was feasible and allowed suppression of GFP over at least 4 days. Furthermore nucleofection was successful for establishing stable FRTL-5 cell clones. In conclusion, this optimized fast and efficient nucleofection protocol offers new properties for the experimental use of FRTL-5 cells.

References

• 1 Ambesi-Impiombato FS, Parks LA, Coon HG. Proc Natl Acad Sci USA. 1980;  77 3455-3459
• 2 Bidey SP, Lambert A, Robertson WR. J Endocrinol. 1988;  119 365-376
• 3 Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Endocr Rev. 2001;  22 631-656
• 4 Santisteban P, Kohn LD, Di Lauro R. J Biol Chem. 1987;  262 4048-4052
• 5 Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke R, Wynford-Thomas D, Eggo M, Ludgate M. Endocrinology. 2003;  144 4018-4030
• 6 Jung HS, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, Lee MK, Kim KW, Chung JH. Endocr J. 2007;  54 275-285
• 7 Kim KS, Jung HS, Chung YJ, Jung TS, Jang HW, Lee MS, Kim KW, Chung JH. J Korean Med Sci. 2008;  23 870-876
• 8 Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES, Korner I, Gan L, Chen S, Castro-Obregon S, Hammermann R, Wolf J, Muller-Hartmann H, Nix M, Siebenkotten G, Kraus G, Lun K. Methods. 2004;  33 151-163

Correspondence